Urine-derived cells for corneal eye disease
Part of Eyes & vision clinical trials.
This trial tests if using special cells from your own urine can help repair the inner layer of your cornea (the clear front part of your eye). It may be an option if you have damage to these cells and have already had at least one cornea transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a damaged inner cornea layer and have had at least one cornea transplant.
- You are between 18 and 85 years old.
- Your cornea cell count is very low (under 500 to 800 cells per square millimeter) or cannot be measured.
- You do not have active eye infections, uncontrolled eye pressure, or certain other health problems like cancer or severe diabetes.
- You are not pregnant, planning pregnancy, or participating in another trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a simple cell treatment for a swollen cornea caused by cataract surgery. It aims to help your cornea become clear again without a full transplant.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
This study tests whether a special substance from stem cells (called secretome) can help heal chronic surface problems on the eye that haven't gotten better with standard treatments. It's for people with a stubborn scratch or defect on the cornea that has lasted more than 14 days.
This trial tests a new artificial cornea device (keratoprosthesis) for people with severe corneal scarring or damage who cannot see well and are at high risk for corneal transplant failure. The goal is to restore vision and improve quality of life.
This Phase 1 trial tests a new, lab-made tissue transplant to improve corneal clarity in people with certain types of corneal endothelium failure (eye swelling) caused by specific conditions. The main goal is to check safety and see if vision and corneal health improve.
This study compares two types of blood-derived treatments (a growth-factor enriched plasma product versus your own serum) to see which helps corneal cells heal better in people with aniridia. It may be helpful if you need improved cornea healing, but you must meet blood-safety and eye-sample requirements.
Hear when a new Cornea Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.